Jump Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,000
Closed -$141K 2095
2025
Q4
$141K Buy
59,000
+32,717
+124% +$89.5K ﹤0.01% 1797
2025
Q3
$74.9K Buy
+26,283
New +$90K ﹤0.01% 1698
2025
Q1
Sell
-15,843
Closed -$112K 1763
2024
Q4
$112K Buy
+15,843
New +$126K ﹤0.01% 1532
2023
Q1
Sell
-31,899
Closed -$339K 1773
2022
Q4
$339K Sell
31,899
-19,351
-38% -$187K 0.02% 970
2022
Q3
$497K Buy
+51,250
New +$679K 0.02% 905
2021
Q4
Sell
-26,738
Closed -$1.34M 1520
2021
Q3
$1.34M Sell
26,738
-22,362
-46% -$1.22M 0.1% 230
2021
Q2
$2.73M Buy
49,100
+27,979
+132% +$1.49M 0.26% 46
2021
Q1
$988K Sell
21,121
-3,459
-14% -$168K 0.09% 233
2020
Q4
$1.07M Buy
24,580
+15,717
+177% +$580K 0.18% 148
2020
Q3
$324K Buy
+8,863
New +$301K 0.07% 472

Other funds holding HCAT

Jump Financial's HCAT Position: Q1 2026 in Review

Jump Financial sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 59,000 shares — an estimated $141K sold.

Jump Financial first reported a position in HCAT in Q3 2020 and held it in 10 quarters. The position peaked at $2.73M in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Jump Financial reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 59,000 Health Catalyst shares in Q1 2026, an estimated $141K.
  • Jump Financial first reported a position in Health Catalyst in Q3 2020 and held it in 10 quarters.
  • Jump Financial's Health Catalyst position peaked at $2.73M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.